Ted DeFrank, Leda Notchey, Mario Alfano, Tyler Aldredge, Andrew von Eschenbach, Lester Crawford | GenomeWeb
Sample-prep kit maker Proteopure has appointed Ted DeFrank to its board of directors, the company said last week.
 
DeFrank is president of management consulting company Dalton Enterprises and formerly was president of Pierce Biotechnology, COO of Invitrogen and vice president of operations at Stratagene.  
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.